Plasma soluble CD30 level correlates negatively with age in children

Journal of Microbiology, Immunology and Infection

Volumn 40, Issue 2, 2007, Pages 168-172

  Chen, Jung Yu ^a   Fu, Lin Shien ^a   Chu, Jao Jia ^a   Chen, Hou Chuan ^a   Chi, Chin Shiang ^a  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Age factors; Antigens, CD30; Cytokines; T lymphocytes

Indexed keywords

CD30 ANTIGEN;

ARTICLE; ATOPY; B LYMPHOCYTE; CHILD; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DISEASE MARKER; FEMALE; HUMAN; IMMUNOREGULATION; MAJOR CLINICAL STUDY; MALE; TH1 CELL; TH2 CELL;

AGING; ANTIGENS, CD30; B-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; HYPERSENSITIVITY, IMMEDIATE; MALE; T-LYMPHOCYTES;

EID: 34347253598     PISSN: 16841182     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Leung DY. Atopic dermatitis: the skin as a window into the pathogenesis of chronic allergic diseases. J Allergy Clin Immunol. 1995;96:302-19.
2. Leung DY. Pathogenesis of atopic dermatitis. J Allergy Clin Immunol. 1999;104:S99-108.
3. Cooper KD. Atopic dermatitis: recent trends in pathogenesis and therapy. J Invest Dermatol. 1994;102:128-37.
4. Grewe M, Bruijnzeel-Koomen CA, Schopf E, Thepen T, Langeveld-Wildschut AG, Ruzicka T, et al. A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol Today. 1998;19:359-61.
5. Mosmann TR, Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today. 1996;17:138-46.
6. Kagi MK, Wuthrich B, Montano E, Barandum J, Blaser K, Walker C. Differential cytokine profiles in peripheral blood lymphocyte supernatants and skin biopsies from patients with different forms of atopic dermatitis, psoriasis and normal individuals. Int Arch Allergy Immunol. 1994;103:332-40.
7. Nakazawa M, Sugi N, Kawaguchi H, Ishii N, Nakajima H, Minami M. Predominance of type 2 cytokine-producing CD4+ and CD8+ cells in patients with atopic dermatitis. J Allergy Clin Immunol. 1997;99:673-82.
8. Hamid Q, Boguniewicz M, Leun DY. Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis. J Clin Invest. 1994;94:870-6.
9. Thepen T, Langeveld-Wildschut EG, Bihari IC, van Wichen DF, van Reijsen FC, Mudde GC, et al. Biphasic response against aeroallergen in atopic dermatitis showing a switch from an initial TH2 response to a TH1 response in situ: an immunocytochemical study. J Allergy Clin Immunol. 1996; 97:828-37.
10. Robinson DS, Hamid Q, Ying S, Tsicopoulos A, Barkans J, Bentley AM, et al. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med. 1992; 326:298-304.
11. Prescott SL, Macaubas C, Smallacombe T, Holt BJ, Sly PD, Holt PG. Development of allergen-specific T-cell memory in atopic and normal children. Lancet. 1999;353:196-200.
12. Jung T, Lack G, Schauer U, Uberuck W, Renz H, Gelfand EW, et al. Decreased frequency of interferon-gamma- and interleukin-2-producing cells in patients with atopic diseases measured at the single cell level. J Allergy Clin Immunol. 1995; 96:515-27.
13. Babu KS, Arshad SH. The role of allergy in the development of airway inflammation in children. Paediatr Respir Rev. 2003; 4:40-6.
14. Durkop H, Latza U, Hummel M, Eitelbach F, Seed B, Stein H. Molecular cloning and expression of a new member of the nerve growth factor family that is characteristic for Hodgkin's disease. Cell. 1992;68:421-7.
15. Schwab U, Stein H, Gerdes J, Lemke H, Kirchner H, Schaadt M, et al. Production of a monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin's disease and a subset of normal lymphoid cells. Nature. 1982;299:65-7.
16. Del Prete G, De Carli M, Almerigogna F, Daniel CK, D'Elios MM, Zancuoghi G, et al. Preferential expression of CD30 by human CD4+ T cells producing Th2-type cytokines. FASEB J. 1995;9:81-6.
17. Romagnani S, Del Prete G, Maggi E, Chilosi M, Caligaris-Cappio F, Pizzolo G. CD30 and type 2 T helper (Th2) responses. J Leukoc Biol. 1995;57:726-30.
18. Bengtsson A, Holm L, Back O, Fransson J, Scheynius A. Elevated serum levels of soluble CD30 in patients with atopic dermatitis (AD). Clin Exp Immunol. 1997;109:533-7.
19. Frezzolini A, Paradisi M, Ruffelli M, Cadoni S, De Pita O. Soluble CD30 in pediatric patients with atopic dermatitis. Allergy. 1997;52:106-9.
20. Katoh N, Hirano S, Suehiro M, Ikenaga K, Yamashita T, Sugawara N, et al. Soluble CD30 is more relevant to disease activity of atopic dermatitis than soluble CD26. Clin Exp Immunol. 2000;121:187-92.
21. Dummer W, Brocker EB, Bastian BC. Elevated serum levels of soluble CD30 are associated with atopic dermatitis, but not with respiratory atopic disorders and allergic contact dermatitis. Br J Dermatol. 1997;137:185-7.
22. GINA Guidelines. Global Strategy for Asthma Management and Prevention. NIH Publication No 02-3659. Bethesda, MA, USA: National Institutes of Health; National Heart, Lung, and Blood Institute; 2002:Ch 5, p72. Available from: http://www. ginasthma.com/Guidelineitem.asp?l1=2&12=1&intId=82& archived=1
23. Meltzer EO, Jalowayski AA, Orgel HA, Harris AG. Subjective and objective assessments in patients with seasonal allergic rhinitis: effects of therapy with mometasone furoate nasal spray. J Allergy Clin Immunol. 1998;102:39-49.
24. Severity scoring of atopic dermatitis: the SORAD index. Consensus report of the European Task Force on Atopic Dermatitis. Dermatology. 1993;186:23-31.
25. Krampera M, Vinante F, Tavecchia L, Morosato L, Chilosi M, Romagnani S, et al. Progressive polarization towards a T helper/ cytotoxic type-1 cytokine pattern during age-dependent maturation of the immune response inversely correlates with CD30 cell expression and serum concentration. Clin Exp Immunol. 1999;117:291-7.
26. Cavagni G, Caffarelli C, Facchetti F, Brugnoni D, Notarangelo LD, Tosoni C, et al. Cutaneous CD30+ cells in children with atopic dermatitis. Int Arch Allergy Immunol. 2000;121:224-8.
27. Blanco Quiros A, Arranz E, Hoyos C, Carrasco JA, Andion R. Different serum interleukin-12 and sCD30 levels in food and pollen-sensitized children. Pediatr Allergy Immunol. 1999;10: 235-40.